See more : Spectaire Holdings Inc. (SPEC) Income Statement Analysis – Financial Results
Complete financial analysis of SK Chemicals Co.,Ltd (285130.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SK Chemicals Co.,Ltd, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- FIRST FINTEC LIMITED (FIRSTFIN.BO) Income Statement Analysis – Financial Results
- Yeahka Limited (YHEKF) Income Statement Analysis – Financial Results
- First Capital, Inc. (FCAP) Income Statement Analysis – Financial Results
- Arunjyoti Bio Ventures Limited (ABVL.BO) Income Statement Analysis – Financial Results
- Rice Acquisition Corp. II (RONI) Income Statement Analysis – Financial Results
SK Chemicals Co.,Ltd (285130.KS)
About SK Chemicals Co.,Ltd
SK Chemicals Co., Ltd. provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,748.78B | 1,829.19B | 2,089.63B | 1,214.71B | 1,427.19B | 1,367.72B | 87.84B |
| Cost of Revenue | 1,275.85B | 1,214.10B | 1,208.25B | 864.40B | 1,101.18B | 1,095.29B | 75.15B |
| Gross Profit | 472.93B | 615.09B | 881.38B | 350.31B | 326.01B | 272.43B | 12.69B |
| Gross Profit Ratio | 27.04% | 33.63% | 42.18% | 28.84% | 22.84% | 19.92% | 14.45% |
| Research & Development | 130.29B | 100.22B | 85.89B | 65.78B | 68.12B | 60.04B | 4.76B |
| General & Administrative | 26.29B | 22.91B | 16.69B | 14.70B | 17.85B | 15.75B | 1.31B |
| Selling & Marketing | 93.98B | 126.69B | 95.72B | 61.60B | 63.11B | 67.97B | 7.43B |
| SG&A | 120.27B | 149.60B | 112.41B | 76.30B | 80.96B | 83.71B | 8.74B |
| Other Expenses | 139.07B | 134.79B | 127.73B | 101.95B | 96.58B | 1.78B | -1.05B |
| Operating Expenses | 389.63B | 384.61B | 326.02B | 244.03B | 245.67B | 226.70B | 21.87B |
| Cost & Expenses | 1,665.08B | 1,598.71B | 1,534.28B | 1,108.43B | 1,346.85B | 1,321.99B | 97.02B |
| Interest Income | 19.43B | 7.26B | 2.27B | 606.53M | 854.58M | 703.64M | 125.40M |
| Interest Expense | 15.71B | 15.46B | 10.60B | 24.39B | 33.27B | 31.74B | 2.31B |
| Depreciation & Amortization | 112.89B | 91.47B | 79.48B | 72.40B | 92.72B | 88.43B | 7.40B |
| EBITDA | 197.35B | 321.85B | 627.08B | 215.59B | 107.84B | 125.33B | -2.88B |
| EBITDA Ratio | 11.29% | 18.63% | 30.54% | 17.41% | 11.84% | 10.01% | -2.78% |
| Operating Income | 83.30B | 230.48B | 555.19B | 106.28B | 80.34B | 45.73B | -9.18B |
| Operating Income Ratio | 4.76% | 12.60% | 26.57% | 8.75% | 5.63% | 3.34% | -10.45% |
| Total Other Income/Expenses | -30.88B | 6.22B | -16.56B | -29.49B | -60.83B | -40.57B | -3.42B |
| Income Before Tax | 52.42B | 236.70B | 538.62B | 18.98B | 22.85B | 5.16B | -12.59B |
| Income Before Tax Ratio | 3.00% | 12.94% | 25.78% | 1.56% | 1.60% | 0.38% | -14.34% |
| Income Tax Expense | 4.58B | 5.22B | 168.01B | 10.00B | 17.83B | 21.58B | -2.71B |
| Net Income | 39.86B | 191.27B | 370.61B | 8.97B | 5.02B | 6.03B | -8.54B |
| Net Income Ratio | 2.28% | 10.46% | 17.74% | 0.74% | 0.35% | 0.44% | -9.72% |
| EPS | 2.08K | 9.92K | 18.94K | 469.42 | 255.08 | 308.52 | -436.67 |
| EPS Diluted | 2.08K | 9.92K | 18.94K | 463.41 | 255.08 | 304.67 | -436.67 |
| Weighted Avg Shares Out | 19.19M | 19.29M | 19.57M | 19.12M | 19.69M | 19.54M | 19.55M |
| Weighted Avg Shares Out (Dil) | 19.19M | 19.29M | 19.57M | 19.37M | 19.69M | 19.79M | 19.55M |
Source: https://incomestatements.info
Category: Stock Reports